The Latest Breaking News from FDA

Anti-vax Republicans lawmakers are taking a page from abortion bans — and public health experts are worried

Moderna stock reversed lower Thursday after the FDA granted its Merck-partnered cancer vaccine a breakthrough designation.

The Food and Drug Administration is adding to a list of eye-care products consumers should stop using “immediately” over concerns of possible bacterial contamination that could lead to blindness if infection occurs.

Draft U.S. rules would allow soy, oat, almond and other drinks that bill themselves as “milk” to keep using the name

Demand for abortion pills has soared since the Supreme Court decided to overturn Roe v. Wade.

CBD has shown remarkable efficacy in treating seizure disorders. Now we know why this might be.

Two panels that advise the Food and Drug Administration are recommending that naloxone nasal spray be approved for over-the-counter sale for emergency treatment of opioid overdoses. The Joint Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee voted unanimously to approve the measure. The FDA will…

Apellis Pharmaceuticals snagged FDA approval for the first-ever geographic atrophy treatment, leading APLS stock to surge Tuesday.

The biotech industry is well-positioned to witness significant growth on the backs of soaring demands and government spending. Moreover, given the sector’s defensive nature, quality biotech stocks Amgen (AMGN), Gilead Sciences (GILD), and United Therapeutics Corp. (UTHR) might be solid buys in 2023 that could help you set for life.…

When the U.S. Supreme Court overturned Roe v. Wade last year, freeing states to limit or ban abortion, we knew abortion pills would become a target.

A government document obtained by The Associated Press outlines more than three dozen cases in Liberia where it appears logs were illegally cut or moved out of the country using unofficial channels